By: Peter Loftus, Wall Street Journal From: geneticliteracyproject.org A drug sold by AstraZeneca and Merck & Co. reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found. The finding, which on [June 3] was published online by the New England Journal of Medicine and released at a major …